logo
logo

Virtue Diagnostics Closes $100 Million Series B Funding

Virtue Diagnostics Closes $100 Million Series B Funding

01/06/22, 11:01 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CN.svgshanghai
Money raised
$100 million
Industry
apps
health care
Round Type
series b
Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets. Sequoia China and Morningside Ventures jointly led the investment round with ORIZA Holdings. Existing investors Lilly Asia Ventures and PerkinElmer Ventures participated while HAOYUE Capital was the exclusive financial advisor.

Company Info

Company
Virtue Diagnostics
Location
shanghai, shanghai, china
Additional Info
Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.Our goal is to utilize our diverse technology platforms to provide clinical solutions for patients at all disease stages including early screening, initial diagnosis, treatment monitoring and minimal residual disease management.www.Virtuedx.com